ETF·NYSE
iShares U.S. Medical Devices ETF (IHI)
- Net assets
- $3.45B
- Expense ratio
- 0.37%
- Yield
- 0.51%
- 52-week range
- $47.37 $64.71
IHI ETF forecast today
Where IHI stands today, and what CleaRank Financial AI makes of it.
IHI at a glance
iShares U.S. Medical Devices ETF (IHI): Hold, 56/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($53.02 and $53.55).
- Fund Expense ratio 0.37%, $3.4B in net assets, price down 10.1% over 1 year.
Figures as of October 30, 2026.
CleaRank Financial AI
CleaRank rates iShares U.S. Medical Devices ETF (IHI) Hold, with a model score of 56/100.
The trend lifts the score most: the price is 1.95% above its 200-day average and 2.96% above its 50-day average. One-year performance holds it back most: the price fell 10.05% over the past year. The 50-day average stands at $53.02 and the 200-day at $53.55.
Only on CleaRank
Figures we compute ourselves from IHI's own price history. Tap one to see it in context.
IHI ETF price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $54.59 is 3.0% above the 50-day simple moving average of $53.02.Price above its 200-day average ›
The price is 2.0% above the 200-day simple moving average of $53.55.50-day average below the 200-day ›
The 50-day average ($53.02) is 1.0% below the 200-day average ($53.55), the arrangement of a falling longer-term trend.In the lower half of its 52-week range ›
The price sits at 42% of its 52-week range, between $47.37 and $64.71.
IHI share price
Pick a period: each tab shows how far IHI has moved over it, to the last close.
Today's trading
Where IHI sits inside today's range and its 52-week range.
IHI fund facts and valuation
What the fund holds, what it costs and how it is valued.
Fund checks
2/5Expense ratio above 0.20% ›
The fund charges 0.37% a year, $37.00 on a $10,000 holding.Over $1B in net assets ›
Net assets total $3.4B.One sector above 35% of the fund ›
The largest sector, Healthcare, makes up 100.0% of the fund.Pays a distribution ›
The distribution yield is 0.51%.Price down over one year ›
The price fell 10.05% over the past year.
IHI Fund Facts
iShares U.S. Medical Devices ETF is an exchange-traded fund that seeks to track the Dow Jones U.S. Select Medical Equipment Index, giving investors broad exposure to U.S. companies involved in the medical devices sector. The fund focuses on manufacturers and distributors of medical equipment used in diagnostics, imaging, patient monitoring, surgical procedures, and therapeutic care, including products such as pacemakers, prosthetics, MRI scanners, X-ray machines, and related non-disposable devices.
Sector weights
Total returns, as the fund family reports them
| Period | IHI |
|---|---|
| YTD | -17.35% |
| 1 month | -6.75% |
| 3 months | 3.72% |
| 1 year | -14.45% |
| 3 years | 2.26% |
| 5 years | -3.56% |
| 10 years | 8.20% |
As of Nov 1, 2026, IHI has an expense ratio of 0.37%, $3.45B in net assets and a distribution yield of 0.51%.
Fund reference data as of Nov 1, 2026. Expense ratio and net assets are reported by the fund. The trailing returns are the fund family's own month-end total returns, with distributions included, so they can differ from the price changes elsewhere on this page.
Key statistics
The headline figures for IHI.
What the numbers say
CleaRank Financial AI's reading of IHI's holdings, performance and risks.
Healthcare dominates iShares U.S. Medical Devices ETF (IHI), where it makes up 100.0% of the fund. Because almost every holding sits in that one sector, IHI tends to move in step with it. The fund is a Health offering from iShares and was launched on May 1, 2006.
Owning IHI costs 0.37% each year, which is $37.00 for every $10,000 put into the fund. Net assets stand at $3.4B. Distributions produce a yield of 0.51%, and portfolio turnover is 12%.
With 100.0% of its holdings in Healthcare, the fund depends heavily on one sector. The 30-day standard deviation of IHI's daily returns is 1.22%. The price is 15.64% below its 52-week high of $64.71. The one-year record is a loss of 10.05%.
IHI AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 57.5, in neutral territory.RSI above 50 ›
An RSI of 57.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of IHI
The score, the reasoning behind it, and what could move the price next.
Both moving averages sit under the price, which is the shape of an uptrend for iShares U.S. Medical Devices ETF (IHI): the price of $54.59 is 2.96% above the 50-day average ($53.02) and 1.95% above the 200-day average ($53.55). The averages lag the price: the 50-day is 0.98% below the 200-day. Within its 52-week range of $47.37 to $64.71, the price sits at 42%, 15.64% below the high.
Recent gains are set against a weaker long-term record. Over the past month the price rose 6.73%, and over the past three months it rose 3.96%. Across the past year, though, the price fell 10.05%. The 14-day RSI sits at 57.5, which is neutral territory, and the MACD line is positive.
- The two closest levels to watch are the 52-week high at $64.71, which sits above the price, and the 20-day EMA at $53.80, which sits below it.
- The 14-day RSI stands at 57.5, which is neutral territory, and the MACD line is positive. Stretched momentum would show up as readings above 70 or below 30.
- Costs compound: at 0.37% a year, IHI charges $37.00 on every $10,000 invested.
The uptrend depends on IHI holding above its 50-day average of $53.02 and its 200-day average of $53.55. A close below the 200-day average would be the first sign of that trend weakening. If the price pulls back, the first level it would reach is the 20-day EMA at $53.80.
IHI's next level overhead is the 52-week high of $64.71.
Technical indicators
Momentum and trend for IHI, from its daily closes.
As of October 30, 2026, with IHI at $54.59, its 14-day RSI is 57.5 (neutral territory), its 50-day simple moving average is $53.02 and its 200-day is $53.55.
Calculated by CleaRank on daily closes as of October 30, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What IHI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 30, 2026, IHI's 1-year correlation of daily returns is +0.53 with S&P 500 (SPY), +0.37 with Nasdaq 100 (QQQ), +0.04 with Bitcoin (BTC) and +0.07 with gold (XAU).
IHI trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
IHI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from IHI's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much IHI tends to move, against the market and on its own.
IHI price history and drawdowns
IHI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.22% on an average day (30-day standard deviation of daily returns).Not yet recovered from its worst fall ›
The worst fall was 31.9%, from September 2021 to October 2023; the price is still 16.7% below that peak.Most 1-year holds ended higher ›
74% of 1-year holding periods in the last 10 years ended with a gain.Trailed the S&P 500 since the chart begins ›
$10,000 invested in November 2016 is now worth $25,584, against $41,910 in the S&P 500 (SPY).
IHI Drawdowns & Recovery
As of October 30, 2026, IHI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -31.9% (September 2021 to October 2023); it is still 16.7% below that peak, and 74% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into IHI in November 2016 is worth now, against the same amount in the S&P 500.
Against the market: IHI trailed the S&P 500 over this period: $25,584 against $41,910.
A $10,000 investment in IHI in November 2016 would be worth about $25,584 today with dividends reinvested, compared with about $41,910 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to IHI, and which have not.
Strongest month, November: an average of +4.24%, up in 8 of 9 years.
Weakest month, September: an average of -2.70%, up in 3 of 10 years.
This month, November: has averaged +4.24%, up in 8 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, IHI's strongest calendar month has been November (average +4.24%, up in 8 of 9 years) and its weakest September (average -2.70%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
IHI price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in IHI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in IHI today could grow to about $13,374 by 2030 in the base case, with a 90th-percentile outcome near $22,416 and a 10th-percentile outcome around $7,979. The simulation models price only; at today's 0.51% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
IHI 2030 Scenarios (Monte Carlo)
The same simulation in prices, year by year.
CleaRank's simulation projects a price near $73.01 for IHI by 2030 in the base case, from $54.59 today (1.3x over 4 years). The 10th-percentile path ends near $43.56. These are outcomes of a Monte Carlo simulation run on IHI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $45.34 | $58.71 | $76.00 | |
| 2028 | $43.82 | $63.13 | $90.96 | |
| 2029 | $43.40 | $67.89 | $106 | |
| 2030 | $43.56 | $73.01 | $122 |
Method: a lognormal simulation of IHI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
IHI ETF forecast: questions people ask
Answered from the figures on this page, as of October 30, 2026.